Northern Trust Corp grew its position in Envista Holdings Co. (NYSE:NVST - Free Report) by 21.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,751,643 shares of the company's stock after acquiring an additional 306,019 shares during the period. Northern Trust Corp owned 1.02% of Envista worth $33,789,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also bought and sold shares of the company. Treasurer of the State of North Carolina boosted its stake in Envista by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock valued at $1,458,000 after acquiring an additional 480 shares during the last quarter. Amalgamated Bank boosted its position in Envista by 0.7% during the fourth quarter. Amalgamated Bank now owns 80,380 shares of the company's stock worth $1,551,000 after purchasing an additional 523 shares during the period. GAMMA Investing LLC boosted its position in Envista by 30.5% during the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock worth $44,000 after purchasing an additional 538 shares during the period. M&T Bank Corp increased its stake in shares of Envista by 4.2% in the fourth quarter. M&T Bank Corp now owns 16,621 shares of the company's stock worth $320,000 after purchasing an additional 676 shares in the last quarter. Finally, Assetmark Inc. lifted its stake in shares of Envista by 2.5% during the 4th quarter. Assetmark Inc. now owns 39,624 shares of the company's stock valued at $764,000 after buying an additional 983 shares in the last quarter.
Wall Street Analysts Forecast Growth
NVST has been the topic of a number of recent research reports. Bank of America dropped their price objective on Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Needham & Company LLC restated a "hold" rating on shares of Envista in a research report on Thursday, March 6th. Morgan Stanley set a $16.00 price objective on shares of Envista in a research note on Tuesday, April 15th. Piper Sandler cut their price target on shares of Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Finally, Jefferies Financial Group raised their target price on Envista from $20.00 to $22.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Envista has a consensus rating of "Hold" and a consensus target price of $20.08.
View Our Latest Analysis on Envista
Envista Stock Performance
NYSE NVST traded up $0.15 during trading hours on Tuesday, hitting $18.70. The company's stock had a trading volume of 1,212,792 shares, compared to its average volume of 2,525,463. The company's 50 day simple moving average is $16.50 and its two-hundred day simple moving average is $18.99. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76. The company has a market cap of $3.17 billion, a P/E ratio of -2.88, a price-to-earnings-growth ratio of 1.27 and a beta of 0.97. Envista Holdings Co. has a 12 month low of $14.22 and a 12 month high of $23.00.
Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.04. The firm had revenue of $616.90 million for the quarter, compared to analysts' expectations of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The company's revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.26 EPS. As a group, sell-side analysts expect that Envista Holdings Co. will post 1 EPS for the current fiscal year.
About Envista
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading

Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.